TOPIRAMATE ER 25 MG CAPSULE

Topiramate
$3.7743per EA

Strength

25 mg/1

Manufacturer

Endo USA Inc.

NDC

10370036501

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA205976

On Market Since

5/24/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

+1.3%

3M

-8.5%

6M

-13.7%

1Y

-31.8%

3Y

N/A

5Y

N/A

All

-59.5%